|
12.02.2025 14:36:42
|
Kala Bio CEO Mark Iwicki Resigns, Appoints Todd Bazemore As Interim CEO; Stock Falls In Pre-Market
(RTTNews) - Kala Bio, Inc. (KALA), Wednesday announced the resignation of Chief Executive Officer Mark Iwicki, effective immediately. He will continue to serve as Chair of the Board of Directors of the company.
The company added that its President and Chief Operating Officer Todd Bazemore will be appointed as interim CEO.
Prior to joining the company, Bazemore served as Executive Vice President and Chief Operating Officer of Santhera Pharmaceuticals (USA), Inc.
In the pre-market hours, Kala's stock is moving down 22.17 percent, to $8.47 on the Nasdaq.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Kala Pharmaceuticals Inc Registered Shsmehr Nachrichten
| Keine Nachrichten verfügbar. |
Analysen zu Kala Pharmaceuticals Inc Registered Shsmehr Analysen
Letzte Top-Ranking Nachrichten
Nachrichten
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.